Literature DB >> 15183501

Production and killing of second cancer precursor cells in radiation therapy: in regard to Hall and Wuu (Int J Radiat Oncol Biol Phys 2003;56:83-88).

Robert H Davis.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15183501     DOI： 10.1016/j.ijrobp.2003.09.076

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  7 in total

1.  Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships.

Authors:  Uwe Schneider; Barbara Kaser-Hotz
Journal:  Radiat Environ Biophys       Date:  2005-11-05       Impact factor: 1.925

2.  Risk-optimized proton therapy to minimize radiogenic second cancers.

Authors:  Laura A Rechner; John G Eley; Rebecca M Howell; Rui Zhang; Dragan Mirkovic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2015-04-28       Impact factor: 3.609

3.  Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

4.  Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Marcin Sumila; Judith Robotka
Journal:  Theor Biol Med Model       Date:  2011-07-26       Impact factor: 2.432

5.  Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.

Authors:  Masaya Tamura; Hideyuki Sakurai; Masashi Mizumoto; Satoshi Kamizawa; Shigeyuki Murayama; Haruo Yamashita; Seishin Takao; Ryusuke Suzuki; Hiroki Shirato; Yoichi M Ito
Journal:  J Radiat Res       Date:  2017-05-01       Impact factor: 2.724

6.  Development of clinical application program for radiotherapy induced cancer risk calculation using Monte Carlo engine in volumetric-modulated arc therapy.

Authors:  Dong-Jin Kang; Young-Joo Shin; Seonghoon Jeong; Jae-Yong Jung; Hakjae Lee; Boram Lee
Journal:  Radiat Oncol       Date:  2021-06-12       Impact factor: 3.481

7.  Estimation of the risk of secondary malignancy arising from whole-breast irradiation: comparison of five radiotherapy modalities, including TomoHDA.

Authors:  Eun Young Han; Nava Paudel; Jiwon Sung; Myonggeun Yoon; Weon Kuu Chung; Dong Wook Kim
Journal:  Oncotarget       Date:  2016-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.